Lytic bacteriophages are valuable therapeutic agents against bacterial infections. There is continual effort to obtain new phages to increase the effectivity of phage preparations against emerging phage-resistant strains. Here we described the genomic diversity of spontaneous host-range mutants of kayvirus 812. Five mutant phages were isolated as rare plaques on phage-resistant Staphylococcus aureus strains. The host range of phage 812-derived mutants was 42% higher than the wild type, determined on a set of 186 methicillin-resistant S. aureus strains representing the globally circulating human and livestock-associated clones. Comparative genomics revealed that single-nucleotide polymorphisms from the parental phage 812 population were fixed in next-step mutants, mostly in genes for tail and baseplate components, and the acquired point mutations led to diverse receptor binding proteins in the phage mutants. Numerous genome changes associated with rearrangements between direct repeat motifs or intron loss were found. Alterations occurred in host-takeover and terminal genomic regions or the endolysin gene of mutants that exhibited the highest lytic activity, which implied various mechanisms of overcoming bacterial resistance. The genomic data revealed that Kayvirus spontaneous mutants are free from undesirable genes and their lytic properties proved their suitability for rapidly updating phage therapeutics.

Department of Experimental Biology Faculty of Science Masaryk University Brno 611 37 Czech Republic

National Institute of Public Health Praha 100 42 Czech Republic

National Institute of Public Health Praha 100 42 Czech Republic Department of Clinical Microbiology University Hospital and Faculty of Medicine in Hradec Králové Charles University Hradec Králové 500 05 Czech Republic

Veterinary Research Institute Brno 621 00 Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc20028928

003      

CZ-PrNML

005      

20210114155336.0

007      

ta

008      

210105s2019 xxk f 000 0|eng||

009      

AR

024    7_

$a 10.1038/s41598-019-41868-w $2 doi

035    __

$a (PubMed)30940900

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxk

100    1_

$a Botka, Tibor $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, 611 37, Czech Republic.

245    10

$a Lytic and genomic properties of spontaneous host-range Kayvirus mutants prove their suitability for upgrading phage therapeutics against staphylococci / $c T. Botka, R. Pantůček, I. Mašlaňová, M. Benešík, P. Petráš, V. Růžičková, P. Havlíčková, M. Varga, H. Žemličková, I. Koláčková, M. Florianová, V. Jakubů, R. Karpíšková, J. Doškař,

520    9_

$a Lytic bacteriophages are valuable therapeutic agents against bacterial infections. There is continual effort to obtain new phages to increase the effectivity of phage preparations against emerging phage-resistant strains. Here we described the genomic diversity of spontaneous host-range mutants of kayvirus 812. Five mutant phages were isolated as rare plaques on phage-resistant Staphylococcus aureus strains. The host range of phage 812-derived mutants was 42% higher than the wild type, determined on a set of 186 methicillin-resistant S. aureus strains representing the globally circulating human and livestock-associated clones. Comparative genomics revealed that single-nucleotide polymorphisms from the parental phage 812 population were fixed in next-step mutants, mostly in genes for tail and baseplate components, and the acquired point mutations led to diverse receptor binding proteins in the phage mutants. Numerous genome changes associated with rearrangements between direct repeat motifs or intron loss were found. Alterations occurred in host-takeover and terminal genomic regions or the endolysin gene of mutants that exhibited the highest lytic activity, which implied various mechanisms of overcoming bacterial resistance. The genomic data revealed that Kayvirus spontaneous mutants are free from undesirable genes and their lytic properties proved their suitability for rapidly updating phage therapeutics.

650    _2

$a bakteriofágy $x genetika $7 D001435

650    _2

$a zastoupení bazí $7 D001482

650    _2

$a bakteriální léková rezistence $7 D024881

650    _2

$a délka genomu $7 D059646

650    _2

$a genom virový $7 D016679

650    _2

$a genomika $7 D023281

650    _2

$a methicilin $x farmakologie $7 D008712

650    12

$a mutace $7 D009154

650    _2

$a jednonukleotidový polymorfismus $7 D020641

650    _2

$a Staphylococcus aureus $x růst a vývoj $x virologie $7 D013211

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Pantůček, Roman $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, 611 37, Czech Republic. pantucek@mail.muni.cz.

700    1_

$a Mašlaňová, Ivana $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, 611 37, Czech Republic.

700    1_

$a Benešík, Martin $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, 611 37, Czech Republic.

700    1_

$a Petráš, Petr $u National Institute of Public Health, Praha, 100 42, Czech Republic.

700    1_

$a Růžičková, Vladislava $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, 611 37, Czech Republic.

700    1_

$a Havlíčková, Pavla $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, 611 37, Czech Republic.

700    1_

$a Varga, Marian $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, 611 37, Czech Republic.

700    1_

$a Žemličková, Helena $u National Institute of Public Health, Praha, 100 42, Czech Republic. Department of Clinical Microbiology, University Hospital and Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, 500 05, Czech Republic.

700    1_

$a Koláčková, Ivana $u Veterinary Research Institute, Brno, 621 00, Czech Republic.

700    1_

$a Florianová, Martina $u Veterinary Research Institute, Brno, 621 00, Czech Republic.

700    1_

$a Jakubů, Vladislav $u National Institute of Public Health, Praha, 100 42, Czech Republic.

700    1_

$a Karpíšková, Renáta $u Veterinary Research Institute, Brno, 621 00, Czech Republic.

700    1_

$a Doškař, Jiří $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, 611 37, Czech Republic.

773    0_

$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 9, č. 1 (2019), s. 5475

856    41

$u https://pubmed.ncbi.nlm.nih.gov/30940900 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20210105 $b ABA008

991    __

$a 20210114155334 $b ABA008

999    __

$a ok $b bmc $g 1609263 $s 1120108

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2019 $b 9 $c 1 $d 5475 $e 20190402 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195

GRA    __

$a NV16-29916A $p MZ0

LZP    __

$a Pubmed-20210105